Affordable medication access remains a significant challenge in dermatology. In 2021, 17% of older US adults could not afford their prescriptions.1 Programs like GoodRx and Cost Plus Drugs aim to enhance patient medication access. These digital platforms build on established models, such as the usual and customary pricing models, the Walmart $4 formulary, and discount cards. It is critical to scrutinize these discount platforms鈥� operations and impact.2 We aimed to inform readers about prescription cost-saving platforms and raise questions about their consequences for clinical practice and quality of care.